baber/WOPTO huggingface dataset:
Patent AU-2111183-A (AU)
Title: Implant with organosilicon and biopolymer layers
Inventor: ENGELHARDT ACHIM
IPC: A61C13/09
Filed: 1983-11-09
Abstract: An improved implant is disclosed, having a customary substrate, particularly at least partially of metal, and a one- or multi-layer coating of ceramic, biologically compatible glasses and/or bioactive glasses, the improvement comprising a second type layer covalently bound on said coating of ceramic or bioglass said second type of layer being from polymeric organo-silicon compounds, and said second type of layer being covalently coupled, with or without a coupling molecule, with a third type of layer of a synthetic or natural biopolymer. Also disclosed is a process for producing the implant, by applying in known mariner a coating of ceramic, biologically compatible and/or bioactive glasses onto a substrate of said implant, providing said coating with a second type of layer of polymerized organo-silicon compound (polysiloxane) in covalent connection therewith, and coupling said second type of layer with a third type of layer of a synthetic or natural biopolymer, with or without use of a coupling means.
Patent AU-2134895-A (AU)
Title: Method and device for directly charging an electric furnace with liquid metal from a ladle
Inventor: KAELL NORBERT
IPC: F27D3/14
Filed: 1995-03-21
Abstract: A method and a device for directly feeding liquid metal into an electric furnace. A carriage carrying a ladle filled with molten metal is moved forward into a starting position adjacent the electric furnace then lowered and horizontally translated until the upper rim of the ladle is located over the electric furnace. The ladle is then tipped and gradually raised and translated to keep the upper ladle rim in a position in which the liquid metal can be poured into the furnace. The ladle is tilted back, lowered and horizontally translated to return it to the starting position.
Patent AU-2138995-A (AU)
Title: Ophthalmic composition with decreased viscosity
Inventor: REUNAMAKI TIMO
IPC: A61K47/36
Filed: 1995-03-29
Abstract: PCT No. PCT/FI95/00166 Sec. 371 Date Apr. 2, 1996 Sec. 102(e) Date Apr. 2, 1996 PCT Filed Mar. 29, 1995 PCT Pub. No. WO95/26711 PCT Pub. Date Oct. 12, 1995The present invention is directed to an ophthalmic composition in the form of a topical aqueous solution consisting essentially of an ophthalmologically active agent, an ion sensitive, hydrophilic polymer in an amount a of 0.004 to 1.5% by weight, at least one salt selected from the group of inor ganic salts and buffers in a total amount of from 0.01 to 2.0% by weight, a wetting agent in an amount of 0 to 3.0% by weight, a preservative in an amount of 0 to 0.02% by weight, water, and optionally a pH regulating agent in an amount sufficient to give a pH of 4.0 to 8.0 to the composition, the ratio between salt and polymer components being such that the solution exhibits a viscosity of less than 1000 mPas. The composition contains a sufficient amount of polymer to provide for a controlled absorption of the drug into the eye, its viscosity having been reduced to provide for better handling characteristics.
Patent AU-2153901-A (AU)
Title: Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
Inventor: UTKU NALAN
IPC: A61K35/76
Filed: 2000-10-30
Abstract: Described are generally immune response cDNA TZap7/A, TZap7/B and TZap7 polynucleotides encoding novel proteins involved in modulation of immune responses and antibodies recognizing said proteins. Furthermore, vectors comprising the aforementioned polynucleotides and host cells transformed therewith as well as their use in the production of the above-defined proteins are described. Additionally, pharmaceutical and diagnostic compositions are provided comprising any one of the afore-described polynucleotides, vectors, proteins, or antibodies. Furthermore, methods and uses for modulating immune responses through the novel TZap protein as well as pharmaceutical compositions comprising agents which act on the TZap protein or its ligand are described. Also, the use of said polynucleotides, vectors, proteins or antibodies for the preparation of diagnostic and pharmaceutical compositions for use in organ transplantation, for the treatment of autoimmune, allergic or infectious diseases, or for treatment of tumors is provided.
Patent AU-2302397-A (AU)
Title: Peptidyl compounds having mmp and tnf inhibitory activity
Inventor: BAXTER ANDREW DOUGLAS
IPC: A61P25/00
Filed: 1997-04-04
Abstract: PCT No. PCT/GB97/00957 Sec. 371 Date Oct. 2, 1998 Sec. 102(e) Date Oct. 2, 1998 PCT Filed Apr. 4, 1997 PCT Pub. No. WO97/37973 PCT Pub. Date Oct. 16, 1997Compounds of formula (I) having MMP and TNF inhibitory activity.
Patent AU-2410092-A (AU)
Title: Stable, anticorrosive peracetic/peroxide sterilant
IPC: A61K33/40
Filed: 1992-07-14
Abstract: A stable anticorrosive consists of equilibrium of peracetic acid, acetic acid, H2O2 and an aq. diluent and has 0.001-200 ppm of added stabilisers, 0.001-10 ppm of ionic and nonionic contaminants and no added surfactants. The concn. of added stabiliser is 0.001-100 (esp. .001-10 ppm). A pref. concentrate comprises: (at equilibrium) 16-38 (esp. 23-24) wt.% of H2O2, 2.5-9 (esp. 9-10) wt.% HOAC, 1.5-6 (esp. 4-6) wt.% of HOOAc and balance purified aq. diluent.
Patent AU-2416097-A (AU)
Title: A set-up for feeding timber to a single-log feeder
Inventor: MARKLUND ERLAND
IPC: B27B31/00
Filed: 1997-03-25
Abstract: Plant for feeding timber boards to and through a single-board feeder (2) for elongated timber boards (4). The timber boards are conveyed in mutually sequential relationship while lying on a conveyor (1) transversely to the conveying direction. The conveyor (1) advances the boards to the single-board feeder (2) at a speed of Vin and the feeder operates at a feeding speed Vut which is slower than Vin. Arranged upstream of the single-board feeder (2) and the buffer region (3) adjacent thereto as seen in the conveying direction is a regulator means (5, 6) which retards the boards (4) advanced on the conveyor (1) to a speed Vreg which is slower than Vin, prior to passing boards (4) further to the single-board feeder (2) on the conveyor (1).
Patent AU-2509499-A (AU)
Title: Puncturing device for tomography methods
Inventor: JAGGI KURT
IPC: A61B90/00
Filed: 1999-03-04
Abstract: A puncturing device that can be observed by means of tomography, such as MRI, which can be operated simply, safely and reliably. One embodiment of the invention includes a cuboid body containing a needle guide, which extends to a base area of the cuboid body. The base area is configured for placement on the skin of a patient. Marker bores disposed in the cuboid body and containing a contrast medium make it possible to precisely align the needle guide with a tomography picture plane in that the images of the bores have to assume a particular mutual configuration on a monitor. This allows a puncture needle used with the needle guide to be observed along its entire path on tomograms.
Patent AU-2511299-A (AU)
Title: Method and device for producing fibrous materials from thermoplastic materials
Inventor: VOLOKITIN GENNADY GEORGIEVICH
IPC: D01D5/08
Filed: 1999-01-07
Abstract: The invention relates to a method for producing fibrous materials from thermoplastic material, wherein thermoplastic material is molten and fed into a rotating reactor to form a molten film and the fibers are formed on and stretched out along an open edge of the reactor. The fibers are formed on the reactor edge without using nozzles or ducts that are susceptible to clogging so that the rotating reactor is heated in such a way that the molten film has a temperature close to decomposition temperature of the thermic plastic material and the reactor is rotated on the edge at an orbital speed of no less than 10 m/s.
Patent AU-2524384-A (AU)
Title: Pressure transducer
Inventor: LARNER DONALD ALEXANDER
IPC: G01L7/16
Filed: 1984-03-02
Abstract: A differential pressure gauge 10 utilizes a piston member 18 provided with a series of grooves 19 right around it, so that the piston member 18 itself forms the rack of a rack-and-pinion device (pinion 22) for converting linear displacement of the piston member into rotary displacement of the pinion. For sensitivity and accuracy, the seal between the piston member 18 and the passage 13 is a hard-surface-to-hard-surface engagement between substantial (total) hard surface areas at any one time of the passage 13 and the piston member 18, including regions of the surface area of the piston member 18 intermediate mutually adjacent end ones of the grooves 19. In this way, the gauge is insensitive to the base pressure, there being no soft seals to deform under pressure. A magnetic coupling is used through the wall of the housing, which can thus be made completely pressure-tight. One embodiment indicates a reverse differential pressure by allowing the piston to travel beyond the normal end position upon overcoming the preload of a second spring.
Patent AU-2698988-A (AU)
Title: Tricyclic compounds
Inventor: WALSER ARMIN
IPC: C07D519/00
Filed: 1988-12-16
Abstract: The novel compounds of the general formula <CHEM>  wherein X is -CH=CH- or S;  R1 is lower alkyl, lower alkoxy or trifluoromethyl; R2 is hydrogen, lower alkyl, lower alkoxy, hydroxy or lower alkanoyloxy; R3 and R4, independently, are hydrogen, chlorine, fluorine, lower alkyl or lower alkoxy; R5 is a radical of the formula R6-(CH2)n-C IDENTICAL C- or R7-O-(CH2)m-C IDENTICAL C-, R6 and R7 are aryl or a heterocyclic radical; n is an integer from 0 to 2; m is an integer from 1 to 2 and s is an integer from 0 to 1; with the proviso that, when s is 1, R2 cannot be hydroxy, lower alkoxy or lower alkanoyloxy; that, when n is 0, R6 must be attached through a carbon to carbon bond, and that R7 is always attached through a carbon to oxygen bond, and, when at least one asymmetric centre is present, their enantiomers and racemates and pharmaceutically acceptable acid addition salts thereof exhibit activity as platelet activating factor (PAF) antagonists and are, therefore, useful in disease states characterized by excess platelet activating factor or for the prevention and treatment of cardiovascular diseases, pulmanory diseases, immunological disorders, inflammatory diseases, dermatological disorders, shocks or transplant rejections.
Patent AU-2801389-A (AU)
Title: Antenna structure for providing a uniform field
Inventor: MURDOCH GRAHAM ALEXANDER MUNRO
IPC: H03J3/24
Filed: 1988-12-12
Abstract: The present application discloses an adjustable reactance, and a device for controlling the value of a reactance. The invention has application in tuning circuits and the control of electrical devices, such as electric motors. The invention, in particular, discloses an apparatus and method for the truncation of voltage across or current through a reactance element. <IMAGE>
Patent AU-2817599-A (AU)
Title: Electrically conductive microcapillary composite matrix and method for producing same
Inventor: SCHWARZ WOLFGANG
IPC: C04B28/24
Filed: 1999-03-08
Abstract: Microcapillary composite matrix consists of an electroconductive paint or coating on mortar or cement concrete on the surface layer of the concrete. The fraction of capillaries with a diameter \~ 50 nm is over 25%, preferably over 35% and higher than the fraction of microcapillaries to the total capillary porosity of the underlying concrete or mortar. The microcapillaries are interconnected and form a network with the capillary network in the concrete. The matrix has high ion conductivity, is resistant to weak acids and has a resistivity less than 25, preferably less than 5 ohm/cm. Its negative pore water pressure is higher than that in the concrete or mortar.  An Independent claim is also included for the production of the matrix by applying a suitable paint.
Patent AU-3009397-A (AU)
Title: Hematopoietic cytokine receptor
Inventor: BAUMGARTNER JAMES W
IPC: A61P37/02
Filed: 1997-05-19
Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissues, including B-cells and T-cells. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells  in vitro  and  in vivo . Ligand-binding receptor polypeptides can also be used to block ligand activity  in vitro  and  in vivo .
Patent AU-3132993-A (AU)
Title: Electrothermal printing ink with monodispersed synthetic pigment particles and method and apparatus for electronic printing therewith
IPC: C09D11/02
Filed: 1992-11-12
Abstract: A printing ink comprises a clear, transparent, polymeric carrier material and uniform, colloidal size charged color particles evenly dispersed therein. The carrier and the particles are adhesively bonded to one another so as to form a matrix which can collectively respond to an externally imposed electrostatic field to promote co-movement of a "bite" of ink to an imaging medium without change of the bulk particle/carrier ratio. During the printing process, the ink is melted and exposed to electrostatically charged latent image areas on a heated image cylinder, resulting in the transfer of the ink thereto in proportion to the electrostatic field strength. The ink exhibits a relatively sharp liquid-to-solid transition, thereby enabling rapid ink solidification and complete transfer from the imaging medium to the relatively cool printing substrate. Also disclosed is a printing method and apparatus that facilitate continuous, variable and on-demand color printing in conjunction with the ink. Use of essentially monodispersed, color-coated, colloidal size, spherical particles in the ink results in excellent color purity and chromaticity range.
Patent AU-3165897-A (AU)
Title: A gas hob
Inventor: ESKILDSEN CHRISTIAN
IPC: F24C15/10
Filed: 1997-06-16
Abstract: A traditional gas burner for a hob is centrally located below a support grille and surrounded by a dish-shaped depression for spillage. Control of the power of the burner is usually only by the control of the total gas supply, even though the burner provides a large number of small flames. The invention provides efficient means of controlling each individual flame (F1a-F4a, F1b-F4b) via individual pipes to orifices, and the required space for this is provided by directing the flames from the outside and towards the center of the cooking vessel. The orifices are placed in the sides of channels providing air supply and exhaust of burnt gases. The channels are formed in what is otherwise a large flat top (A1-A9) of the hob.
Patent AU-3264395-A (AU)
Title: Procedure and device to take off the wrapping material covering multistacked palletized loads
Inventor: GONIZZI GIORGIO
IPC: B65B69/00
Filed: 1995-09-11
Abstract: Procedure to take off the wrapping material covering multistacked palletized loads characterized by the fact that it presents the combination of horizontal cuts (3), made on the top of two opposite sides, with vertical cuts (4) made on the same opposite sides. This procedure can be used to operate both with thermo-shrunk film and stretchable film.
Patent AU-3360393-A (AU)
Title: Improvements in or relating to nucleic acid hybridisation assays
Inventor: CARDY DONALD LEONARD NICHOLAS
IPC: C12Q1/6813
Filed: 1993-01-18
Abstract: Disclosed is a novel composition for use in nucleic acid hybridisation assays comprising a labelled nucleic acid hybridisation probe (or precursor thereof) reversibly bound in dessicated form to a solid support, said probe (or precursor) being releasable upon the addition of water or an aqueous solution. Also disclosed is a method of performing nucleic acid hybridisation assays which employs the novel composition and a kit for performing said assay method.
Patent AU-3388193-A (AU)
Title: Intaglio printing machine
Inventor: GERMANN ALBRECHT JOSEF
IPC: B41F11/02
Filed: 1993-03-02
Abstract: The intaglio printing machine has three machine stands (I, II, III). Essentially, the impression cylinder (1) and the plate cylinder (2) are mounted in the first stand (I), the stencil rollers (10) and the inking unit (11) are mounted in the second stand (II), and the color-collect cylinder (8) is mounted in the third stand (III). The third stand (III) is adjustable in such a way that it can be removed from the space between the first and second stands and brought into an inoperative position, so that it is possible to bring the second stand (II) up against the first stand (I) to form an intaglio printing machine with direct inking. This results in a convertible intaglio printing machine by means of which a collect intaglio print can be made in a first operating position, in which all three stands assume their working position, and a direct intaglio print can be made in a second operating position, with the use of only the first and second stands.
Patent AU-3397795-A (AU)
Title: A method for production of ethyl alcohol
Inventor: VALKANAS GEORGE N
IPC: C12P7/06
Filed: 1995-09-13
Abstract: PCT No. PCT/GR95/00016 Sec. 371 Date Jul. 19, 1996 Sec. 102(e) Date Jul. 19, 1996 PCT Filed Sep. 13, 1995 PCT Pub. No. WO96/08575 PCT Pub. Date Mar. 21, 1996The invention describes a method for the economic production of ethyl alcohol involving dehydration of the alcohol in an adsorption-desorption process using ion exchange resins which have been swollen in water from about 50 to 300 times their weight.
Patent AU-3478084-A (AU)
Title: Flexible synthetic material bag with handle that doubles as a stropper
Inventor: GAUTIER RAOUL
IPC: B65D75/52
Filed: 1984-10-29
Abstract: A bag made of flexible synthetic material is provided with a removable stiffening element that can serve as both a handle and a stopper element after the bag has been opened.
Patent AU-3512497-A (AU)
Title: Water miscible erythromycin solutions
Inventor: HOPPONEN RAYMOND E
IPC: A61K31/7048
Filed: 1997-07-02
Abstract: Water miscible pharmaceutical compositions containing up to about 40% of erythromycin prepared by reaction with acetic acid in a non-aqueous water miscible organic solvent system.
Patent AU-3662389-A (AU)
Title: Protein curculin and application of the same
Inventor: KURIHARA YOSHIE
IPC: A23L27/12
Filed: 1989-06-20
Abstract: A protein curuculin obtained by extracting from fresh Curuculigo latifolia fruits or dried fruits thereof with an aqueous solution of a salt of a concentration of at least 0.01 M; a taste-modifier for a sour material comprising fresh Curuculigo latifolia fruits, dried fruits thereof or a curuculin-containing material obtained therefrom; a chewing gum composition comprising fresh Curuculigo latifolia fruits, dried fruits thereof or a curuculin-containing material obtained therefrom; and a mouth-wash composition comprising fresh Curuculigo latifolia fruits, dried fruits thereof or curuculin-containing material obtained therefrom are disclosed.
Patent AU-3668289-A (AU)
Title: Novel esters of estramustine
Inventor: HANSEN BERTIL VALDEMAR
IPC: C07J41/00
Filed: 1989-06-21
Abstract: The present invention concerns novel compounds having the general formula <CHEM> wherein R<1>, R<2> and R<3> are selected from the group consisting of hydrogen or lower alkyl having 1-4 carbon atoms, wherein R<2> and R<3> together with the N atom can also form a ring having 2-5 carbon atoms and wherein n is 0, 1 or 2, and pharmaceutically acceptable salts thereof. The compounds according to the invention are useful as anticancer agents.
Patent AU-3676295-A (AU)
Title: Method and apparatus for decoder optimization
Inventor: DENT PAUL W
IPC: H03M13/23
Filed: 1995-09-13
Abstract: In a communications system, a message to be transmitted is used to generate an error detection checkword. Both the message and checkword are encoded into a communication traffic signal using an error correction code. An error correction decoder decodes a received traffic signal, generating a plurality of candidate decoded signals and quantitative measurements of the reliability of the candidates. An error detection calculator tests the most reliable candidate for compliance between its decoded message and checkword. If there is compliance, that candidate and its decoded message are selected. If there is no compliance, the next most reliable candidate is tested for compliance, the selection process continuing until compliance is found. If no compliance is found among all the candidates, an error corrector scrutinizes the most reliable candidate for the presence of a correctable error, and the corrected candidate is re-tested for compliance. If there is still no compliance, the next most reliable candidate is scrutinized for the presence of a correctable error, and the corrected candidate is retested for compliance, the process continuing until compliance is found, up to the limits of the error correction capability of the error corrector.
Patent AU-3687593-A (AU)
Title: A method of producing a factor VIII preparation
Inventor: EIBL JOHANN
IPC: A61L2/18
Filed: 1993-04-14
Abstract: The invention relates to a process for the preparation of a highly purified, virus-safe factor VIII preparation, characterised by combination of the following measures   a) a chromatographic purification of a factor VIII-containing fraction, b) a surfactant treatment of the factor VIII in aqueous solution with a surfactant/protein ratio of 1:1 to 66:1 and c) a heat treatment of the factor VIII preparation in the solid state.
Patent AU-3698895-A (AU)
Title: Process for preparing an aqueous polymer dispersion
Inventor: BAUMSTARK ROLAND
IPC: C08F6/00
Filed: 1995-09-23
Abstract: PCT No. PCT/EP95/03770 Sec. 371 Date Apr. 3, 1997 Sec. 102(e) Date Apr. 3, 1997 PCT Filed Sep. 23, 1995 PCT Pub. No. WO96/10588 PCT Pub. Date Apr. 11, 1996A process for the preparation of an aqueous polymer emulsion, in which an aqueous emulsion of a polymer which contains at least one chemically bonded monomer having at least one ethylenically unsaturated group is produced in a manner known per se so that the total content of free monomers having at least one ethylenically unsaturated double bond, ie. monomers of this type which are not chemically bonded, in the aqueous polymer emulsion is from >0 to </=1% by weight, based on the polymer content of the aqueous polymer emulsion, and this residual monomer content is then reduced by the action of a free radical redox initiator system comprising at least one oxidizing agent and at least one reducing agent, wherein the redox initiator system comprises, as the reducing agent, one which is present, in aqueous solution, in at least two tautomeric forms in equilibrium with one another (for example aminoiminomethanesulfinic acid and/or the salts thereof).
Patent AU-4040397-A (AU)
Title: Computerized medical diagnostic and treatment advice system including network access
Inventor: ILIFF EDWIN C
IPC: G06F19/00
Filed: 1997-07-11
Abstract: A system and method for providing computerized, knowledge-based medical diagnostic and treatment advice. The medical advice is provided to the general public over networks, such as a telephone network or a computer network. The invention also includes a stand-alone embodiment that may utilize occasional connectivity to a central computer by use of a network, such as the Internet. Two new authoring languages, interactive voice response and speech recognition are used to enable expert and general practitioner knowledge to be encoded for access by the public. "Meta" functions for time-density analysis of a number of factors regarding the number of medical complaints per unit of time are an integral part of the system. A re-enter feature monitors the user's changing condition over time. A sympton severity analysis helps to respond to the changing conditions. System sensitivity factors may be changed at a global level or other levels to adjust the system advice as necessary.